Neuros Medical, a Cleveland, Ohio based neuromodulation company, is focused on the development of proprietary therapies for unmet needs to patients worldwide. The Company’s patented platform technology, High Frequency Nerve Block, is focused on the treatment of chronic post-amputation pain (Phantom Limb Pain and Residual Limb Pain).
Neuros Medical’s technology, created by Drs. Kevin Kilgore and Niloy Bhadra of Case Western Reserve University’s Department of Biomedical Engineering and MetroHealth Medical Center, and developed through funding from the National Institute of Biomedical Imaging and Bioengineering, delivers a high-frequency electrical signal to sensory nerves in the peripheral nervous system to block the pain signal. The system consists of an electrode (also known as a lead) placed around a peripheral nerve and an implantable pulse generator (IPG).
Chronic pain is characterized as pain lasting more than 3 months in duration. Post-amputation pain includes phantom limb, residual limb and neuroma pain impacting nearly one million Americans. There are nearly two million amputees in the U.S. with 185,000 new amputations occurring every year.